We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Servier announced that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases.